- Q1 2024 IMCD NV Earnings Call TranscriptApr 26, 2024€141.7 (-4.90%)Earnings
- Q3 2023 IMCD NV Earnings Call TranscriptNov 10, 2023€126.8 (-0.39%)Earnings
- Q2 2023 IMCD NV Earnings Call TranscriptAug 04, 2023€128.15 (-1.42%)Earnings
- Q1 2023 IMCD NV Earnings Call TranscriptApr 26, 2023€137.9 (-3.97%)Earnings
- Q4 2022 IMCD NV Earnings Call TranscriptFeb 24, 2023€143.4 (-2.45%)Earnings
- Q3 2022 IMCD NV Earnings Call TranscriptNov 10, 2022€141.5 (+6.31%)Earnings
- Q2 2022 IMCD NV Earnings Call TranscriptAug 04, 2022€152.8 (+0.20%)Earnings
- Q1 2022 IMCD NV Earnings Call TranscriptApr 29, 2022€152.7 (-1.13%)Earnings
- Q4 2021 IMCD NV Earnings Call TranscriptFeb 25, 2022€141.35 (+0.60%)Earnings
- Q3 2021 IMCD NV Earnings Call TranscriptNov 09, 2021€197.05 (+0.38%)Earnings
- Q2 2021 IMCD NV Earnings Call TranscriptAug 04, 2021€163.15 (+10.46%)Earnings
- Q1 2021 IMCD NV Earnings Call TranscriptApr 29, 2021€120.6 (-1.19%)Earnings
- Full Year 2020 IMCD NV Earnings Call TranscriptFeb 26, 2021€101.95 (-1.35%)Earnings
- Nine Months 2020 IMCD NV Earnings Call TranscriptNov 11, 2020€105.35 (+2.13%)Earnings
- IMCD N.V., Signet Excipients Private Limited - M&A Call TranscriptSep 15, 2020
- Half Year 2020 IMCD NV Earnings Call TranscriptAug 18, 2020€90.68 (-0.31%)Earnings
- Q1 2020 IMCD NV Trading Update Call TranscriptApr 20, 2020
- Full Year 2019 IMCD NV Earnings Call TranscriptFeb 27, 2020€76.6 (+1.26%)Earnings
- Nine Months 2019 IMCD NV Earnings Call TranscriptNov 12, 2019€72.9 (+1.32%)Earnings
- Half Year 2019 IMCD NV Earnings Call TranscriptAug 16, 2019€62 (-15.13%)Earnings
- Q1 2019 IMCD NV Earnings Call TranscriptMay 08, 2019€71.7 (+2.94%)Earnings
- Full Year 2018 IMCD NV Earnings Call TranscriptMar 01, 2019€69Earnings
Q4 2021 IMCD NV Earnings Call Transcript
Ladies and gentlemen, thank you for holding, and welcome to the Full Year 2021 Results Analyst Call of IMCD. (Operator Instructions) I would like to hand over the conference to Mr. Pieter van der Slikke. Go ahead, please, sir.
Yes. Good morning, everybody, and welcome to this call. As usual, I'm here with Hans Kooijmans, CFO. I will start with some opening remarks and then Hans will take over. And after that, of course, we will be happy to answer your questions.
As you could have seen from the press release, 2021 was an excellent year for IMCD with a record result. Our EBITA increased with 54% and our cash earnings per share with 53%. We saw very healthy business activities in all regions and our growth came from increased demand, so volume growth, increased pricing, new product lines that we started and acquisitions.
I want to emphasize that other than what some people write, it's not only price increase, it's also predominantly volume growth. It's gratifying to see
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)